<DOC>
	<DOCNO>NCT00391417</DOCNO>
	<brief_summary>The purpose study determine efficacy safety topical estradiol gel treatment hot flush postmenopausal woman .</brief_summary>
	<brief_title>Efficacy Safety Topical Estradiol Gel Treatment Postmenopausal Symptoms</brief_title>
	<detailed_description>Estrogens group hormone play important role normal sexual reproductive development woman . Estrogens serve many function body . They stimulate oocyte maturation endometrial growth , decrease bone resorption , initiate development secondary sex characteristic , maintain reproductive organ gland , affect activity central nervous system . At menopause , decrease estrogen concentration often accompany vascular instability ( hot flush night sweat ) , rise incidence heart disease , increase rate bone loss . Estrogen available oral drug , transdermal patch , gel lotion . Transdermal estrogen preferable compare oral , since avoids first-pass metabolism liver . Since release WHI finding , current treatment recommendation lowest effective dose short period time treat postmenopausal symptom . Comparison : Three dos transdermal estradiol gel compare placebo treatment vasomotor vulvovaginal atrophy symptom postmenopausal woman .</detailed_description>
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Postmenopausal woman serum estradiol level less equal 20 pg per mL serum FSH great 40 mIU per mL Pathological cancer finding screen abnormal endometrium serious hepatic , renal cardiac disease</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>hot flush</keyword>
	<keyword>hot flash</keyword>
	<keyword>estrogen</keyword>
	<keyword>vaginal atrophy</keyword>
</DOC>